Position in ABCL
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$360,770
+$194,200 QoQ
Shares Held
45,958
-3.7% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#72
of 150 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABCL Over Time
Shares Held
Position Value (USD)
Derivatives in ABCL
reported options exposure · as of Jun 30, 2026CallValue
$9,420
CallShares
1,200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Tradition Wealth Management, LLC holds $1,433,579 across 6 Biotechnology names. ABCL ranks #2 (25.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TGTX |
Tg Therapeutics, Inc.
|
6,954 | $382,052 | |
| 2 | ABCL |
AbCellera Biologics Inc.
This page
|
45,958 | $360,770 | |
| 3 | CELC |
Celcuity Inc.
|
2,323 | $243,032 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
463 | $229,985 | |
| 5 | RXRX |
Recursion Pharmaceuticals, Inc.
|
53,657 | $196,921 | |
| 6 | HYFT |
MindWalk Holdings Corp.
|
13,177 | $20,819 |
All Filings in ABCL
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,420 | 1,200 | Call | Sole | 2026-08-11 | |
| 2026-06-30 | $360,770 | 45,958 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $166,570 | 47,728 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $4,537 | 1,300 | Call | Sole | 2026-05-15 | |
| 2025-12-31 | $161,116 | 47,110 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $181,774 | 36,138 | Shares | Sole | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||